InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

Current share price for DXB : $0.238 0.003 (1.04%)+

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$143 Investor Webinar and Presentation 1 May 2025 9:22AM $0.480 $0.238 fallen by 50.52%
$143 Dimerix Licenses DMX-200 in the US 1 May 2025 9:10AM $0.480 $0.238 fallen by 50.52%
$143 Quarterly Appendix 4C and Activities Report 30 Apr 2025 12:01PM $0.480 $0.238 fallen by 50.52%
$143 Trading Halt 29 Apr 2025 8:31AM $0.480 $0.238 fallen by 50.52%
$143 Application for quotation of securities - DXB 28 Apr 2025 2:43PM $0.480 $0.238 fallen by 50.52%
$143 FDA confirms Proteinuria as Primary Endpoint for US approval 28 Apr 2025 8:32AM $0.455 $0.238 fallen by 47.80%
$143 Application for quotation of securities - DXB 22 Apr 2025 1:45PM $0.413 $0.238 fallen by 42.42%
$143 Application for quotation of securities - DXB 16 Apr 2025 2:54PM $0.415 $0.238 fallen by 42.77%
$143 Dimerix to Present at ASX CEO Connect 15 Apr 2025 8:24AM $0.420 $0.238 fallen by 43.45%
$143 Application for quotation of securities - DXB 10 Apr 2025 1:58PM $0.375 $0.238 fallen by 36.67%
$143 Securities Trading Policy Update 8 Apr 2025 8:25AM $0.355 $0.238 fallen by 33.10%
$143 Application for quotation of securities - DXB 4 Apr 2025 11:47AM $0.410 $0.238 fallen by 42.07%
$143 Application for quotation of securities - DXB 2 Apr 2025 2:13PM $0.435 $0.238 fallen by 45.40%
$143 Dimerix to Present at HealthInvest Summit 2 Apr 2025 8:28AM $0.425 $0.238 fallen by 44.12%
$143 Application for quotation of securities - DXB 28 Mar 2025 12:21PM $0.435 $0.238 fallen by 45.40%
$143 Application for quotation of securities - DXB 26 Mar 2025 1:53PM $0.460 $0.238 fallen by 48.37%
$143 Application for quotation of securities - DXB 20 Mar 2025 2:20PM $0.493 $0.238 fallen by 51.78%
$143 Application for quotation of securities - DXB 14 Mar 2025 2:24PM $0.455 $0.238 fallen by 47.80%
$143 Dimerix to Present at Euroz Hartley Institutional Conference 13 Mar 2025 9:10AM $0.400 $0.238 fallen by 40.63%
$143 Application for quotation of securities - DXB 12 Mar 2025 3:45PM $0.403 $0.238 fallen by 40.99%
$143 S&P DJI Announces March 2025 Quarterly Rebalance 7 Mar 2025 5:01PM $0.415 $0.238 fallen by 42.77%
$143 Application for quotation of securities - DXB 6 Mar 2025 1:21PM $0.440 $0.238 fallen by 46.02%
$143 Dimerix receives initial upfront payment from FUSO 4 Mar 2025 8:33AM $0.440 $0.238 fallen by 46.02%
$143 Application for quotation of securities - DXB 3 Mar 2025 3:08PM $0.443 $0.238 fallen by 46.33%
$143 Investor Presentation 26 Feb 2025 9:31AM $0.485 $0.238 fallen by 51.03%

76 - 100 of 719 results

Page 4 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.